α-Glucosidase inhibitory activities of 10-hydroxy-8(E)-octadecenoic acid: an intermediate of bioconversion of oleic acid to 7,10-dihydroxy-8(E)-octadecenoic acid

New Biotechnology

Volumn 27, Issue 4, 2010, Pages 419-423

  Paul, Souren ^a   Hou, Ching Tsang ^b   Kang, Sun Chul ^a  

^a Daegu University   (South Korea)

^b NATIONAL CENTER FOR AGRICULTURAL UTILIZATION RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSELS; MONOUNSATURATED FATTY ACIDS;

BACTERIAL ISOLATES; BIOLOGICAL POTENTIAL; COMPETITIVE INHIBITION; INHIBITORY ACTIVITY; MEDICINAL PREPARATION; METABOLIC DISORDERS; MICROBIAL CONVERSIONS; PSEUDOMONAS AERUGINOSA;

OLEIC ACID;

10 HYDROXYOCTADECENOIC ACID; 7,10 DIHYDROXYOCTADECENOIC ACID; ACARBOSE; ALPHA GLUCOSIDASE; ALPHA GLUCOSIDASE INHIBITOR; OLEIC ACID; UNCLASSIFIED DRUG; 10-HYDROXY-8-OCTADECENOIC ACID; 7,10-DIHYDROXY-8-OCTADECENOIC ACID; ENZYME INHIBITOR; GLYCOSIDASE INHIBITOR;

ARTICLE; BACTERIUM ISOLATE; BIOTRANSFORMATION; CLINICAL EVALUATION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; ENZYME INHIBITION; INSULIN RELEASE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SPECTROPHOTOMETRY; DRUG EFFECTS; ENZYMOLOGY; IC50; KINETICS; METABOLISM; SACCHAROMYCES CEREVISIAE; TIME;

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA;

ACARBOSE; ALPHA-GLUCOSIDASES; ENZYME INHIBITORS; GLYCOSIDE HYDROLASE INHIBITORS; INHIBITORY CONCENTRATION 50; KINETICS; OLEIC ACIDS; PSEUDOMONAS AERUGINOSA; SACCHAROMYCES CEREVISIAE; TIME FACTORS;

EID: 77955096008     PISSN: 18716784     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbt.2010.04.002     Document Type: Article

References (24)

1. Bagby M.O., Carlson K.D. Chemical and biological conversion of soybean oil for industrial products. Fats for the Future 1989, 301-317. Ellis Horwood Limited Press. R.C. Cambie (Ed.).
2. Wallen L.L., et al. The microbiological production of 10-hydroxystearic acid from oleic acid. Arch. Biochem. Biophys. 1962, 99:249-253.
3. Berdy J. Bioactive microbial metabolites. J. Antibiot. 2005, 58:1-26.
4. Bajpai V.K., et al. Microbial conversion and in vitro and in vivo assessment of bioconverted docosahexaenoic acid (bDHA) used against agricultural plant pathogenic fungi. J. Ind. Microbiol. Biotechnol. 2009, 36:695-704.
5. Carballeira N.M. New advances in fatty acids as antimalarial, antimycobacterial and antifungal agents. Prog. Lipid Res. 2008, 47:50-61.
6. Hou C.T., Bagby M.O. Production of a new compound, 7, 10-dihydroxy-8(E)-octadecenoic acid from oleic acid by Pseudomonas sp. PR3. J. Ind. Microbiol. 1991, 7:123-130.
7. Kim H.R., et al. Effect of metal ions on the production of isomeric 9, 10, 13 (9, 12, 13)-trihydroxy-11E (10E)-octadecenoic acid from linoleic acid by Pseudomonas aeruginosa PR3. Enzyme Microb. Technol. 2001, 25:109-115.
8. Kuo T.M., et al. Fatty acid bioconversions by Pseudomonas aeruginosa PR3. J. Am. Chem. Soc. 1998, 75:875-879.
9. Kuo T.M., et al. Production of a novel compound, 7, 10, 12-trihydroxy-8(E)-octadecenoic acid from ricinoleic acid by Pseudomonas aeruginosa PR3. Curr. Microbiol. 2001, 43:198-203.
10. Kim H., et al. 10(S)-hydroxy-8(E)-octadecenoic acid, an intermediate in the conversion of oleic acid to 7, 10-dihydroxy-8(E)-octadecenoic acid. J. Am. Chem. Soc. 2000, 77:95-99.
11. Hou C.T. Microbial oxidation of unsaturated fatty acids. Adv. Appl. Microbiol. 1995, 41:1-23.
12. Hou C.T., et al. Biotransformation of aliphatic hydrocarbons and fatty acids. Biocatalysis and Biotechnology for Functional Foods and Industrial Products 2006, 227-265. Taylor and Francis Company. Hou, Shaw (Eds.).
13. De Andres C., et al. 7, 10-Dihydroxy-8E-octadecenoic acid produced by Pseudomonas sp. 42A2: evaluation of different cultural parameters of the fermentation. World J. Microbiol. Biotechnol. 1994, 10:106-109.
14. Hou C.T. A novel compound, 12, 13, 17-trihydroxy-9(Z)-octadecenoic acid, from linoleic acid by a new microbial isolate Clavibacter sp. ALA2. J. Am. Oil Chem. Soc. 1996, 73:1359-1362.
15. Matsui T., et al. Alpha-glucosidase inhibitory profile of catechins and theaflavins. J. Agric. Food Chem. 2007, 55:99-105.
16. Gershel L. Type 2 diabetes market. Nat. Rev. Drug Discov. 2005, 4:367-368.
17. Casirola D.M., Frraris R.P. Alpha-glucosidase inhibitors prevent diet-induced increases in intestinal sugar transport in diabetic mice. Metabolism 2006, 55:832-841.
18. Van de Laar F.A., et al. Alpha-glucosidase inhibitors for type 2 diabetes mellitus. Cochrane Database Syst. Rev. 2005, 18:CD003639.
19. Kim Y.M., et al. Inhibitory effect of pine extract on alpha-glucosidase activity and postprandial hyperglycemia. Nutrition 2005, 21:756-761.
20. Chen H., et al. A new method for screening alpha-glucosidase inhibitors and application to marine microorganism. Pharm. Biol. 2004, 42:416-421.
21. Dixon M., Webb E.C. The Enzymes 1979, Longman, pp. 345-348. edn 3.
22. Bajpai V.K., et al. Antifungal action of bioconverted eicosapentaenoic acid against plant pathogenic fungi. Ind. Crop Prod. 2008, 27:136-141.
23. Hara Y., Honda M. The inhibition of a-amylase by tea polyphenols. Agric. Biol. Chem. 1990, 54:1939-1945.
24. Kim M.J., et al. Comparative study of the inhibition of alpha-glucosidase, alpha-amylase, and cyclomaltodextrin glucanosyltransferase by acarbose, isoacarbose, and acarviosine-glucose. Arch. Biochem. Biophys. 1999, 371:277-283.